SODIUM-HF: Study of Dietary Intervention Under 100 MMOL in Heart Failure (SODIUM-HF)
The Long Term Effects of Dietary Sodium Restriction on Clinical Outcomes in Patients With Heart Failure
Sponsor: University of Alberta
A PHASE3 clinical study on Heart Failure, this trial is completed. The trial is conducted by University of Alberta and has accumulated 14 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Feb 2023 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Sep 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE3
-
Sep 2021 — Sep 2022 [monthly]
Active Not Recruiting PHASE3
▶ Show 9 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
May 2019 — Aug 2020 [monthly]
Recruiting PHASE3
-
Feb 2019 — May 2019 [monthly]
Recruiting PHASE3
-
Sep 2018 — Feb 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
May 2017 — Dec 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE3
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Alberta
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Auckland, New Zealand , Brampton, Canada , Calgary, Canada , Camrose, Canada , Chermside, Australia , Christchurch, New Zealand , Darlinghurst, Australia , Delta, Canada , Edmonton, Canada , Halifax, Canada and 13 more locations